List of Tables
Table 1. Musculoskeletal Pain Treatment Market Trends
Table 2. Musculoskeletal Pain Treatment Market Drivers & Opportunity
Table 3. Musculoskeletal Pain Treatment Market Challenges
Table 4. Musculoskeletal Pain Treatment Market Restraints
Table 5. Global Musculoskeletal Pain Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Musculoskeletal Pain Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Musculoskeletal Pain Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Musculoskeletal Pain Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Musculoskeletal Pain Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Musculoskeletal Pain Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Musculoskeletal Pain Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Musculoskeletal Pain Treatment
Table 13. Global Musculoskeletal Pain Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Pain Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Musculoskeletal Pain Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Musculoskeletal Pain Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Musculoskeletal Pain Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Musculoskeletal Pain Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Musculoskeletal Pain Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Musculoskeletal Pain Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Musculoskeletal Pain Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Musculoskeletal Pain Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Musculoskeletal Pain Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Musculoskeletal Pain Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Musculoskeletal Pain Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Musculoskeletal Pain Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Musculoskeletal Pain Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Musculoskeletal Pain Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Musculoskeletal Pain Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Musculoskeletal Pain Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Musculoskeletal Pain Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Musculoskeletal Pain Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Musculoskeletal Pain Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Musculoskeletal Pain Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Musculoskeletal Pain Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Musculoskeletal Pain Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Musculoskeletal Pain Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Musculoskeletal Pain Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Musculoskeletal Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Musculoskeletal Pain Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Musculoskeletal Pain Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Musculoskeletal Pain Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Musculoskeletal Pain Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Musculoskeletal Pain Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Musculoskeletal Pain Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Musculoskeletal Pain Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Musculoskeletal Pain Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Musculoskeletal Pain Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Musculoskeletal Pain Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Musculoskeletal Pain Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Musculoskeletal Pain Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Musculoskeletal Pain Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Musculoskeletal Pain Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Musculoskeletal Pain Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Musculoskeletal Pain Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. Pfizer Inc. Company Information
Table 58. Pfizer Inc. Introduction and Business Overview
Table 59. Pfizer Inc. Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Pfizer Inc. Musculoskeletal Pain Treatment Product Offerings
Table 61. Pfizer Inc. Recent Development
Table 62. Abbvie Inc. Company Information
Table 63. Abbvie Inc. Introduction and Business Overview
Table 64. Abbvie Inc. Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Abbvie Inc. Musculoskeletal Pain Treatment Product Offerings
Table 66. Abbvie Inc. Recent Development
Table 67. Novartis AG Company Information
Table 68. Novartis AG Introduction and Business Overview
Table 69. Novartis AG Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Novartis AG Musculoskeletal Pain Treatment Product Offerings
Table 71. Novartis AG Recent Development
Table 72. Amgen Inc. Company Information
Table 73. Amgen Inc. Introduction and Business Overview
Table 74. Amgen Inc. Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Amgen Inc. Musculoskeletal Pain Treatment Product Offerings
Table 76. Amgen Inc. Recent Development
Table 77. Boehringer Ingelheim International GmbH. Company Information
Table 78. Boehringer Ingelheim International GmbH. Introduction and Business Overview
Table 79. Boehringer Ingelheim International GmbH. Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Boehringer Ingelheim International GmbH. Musculoskeletal Pain Treatment Product Offerings
Table 81. Boehringer Ingelheim International GmbH. Recent Development
Table 82. Merck & Co Inc. Company Information
Table 83. Merck & Co Inc. Introduction and Business Overview
Table 84. Merck & Co Inc. Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Merck & Co Inc. Musculoskeletal Pain Treatment Product Offerings
Table 86. Merck & Co Inc. Recent Development
Table 87. Sun Pharmaceutical Industries Ltd. Company Information
Table 88. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 89. Sun Pharmaceutical Industries Ltd. Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Sun Pharmaceutical Industries Ltd. Musculoskeletal Pain Treatment Product Offerings
Table 91. Sun Pharmaceutical Industries Ltd. Recent Development
Table 92. Teva Pharmaceuticals Industries Ltd. Company Information
Table 93. Teva Pharmaceuticals Industries Ltd. Introduction and Business Overview
Table 94. Teva Pharmaceuticals Industries Ltd. Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Teva Pharmaceuticals Industries Ltd. Musculoskeletal Pain Treatment Product Offerings
Table 96. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 97. AstraZeneca Company Information
Table 98. AstraZeneca Introduction and Business Overview
Table 99. AstraZeneca Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. AstraZeneca Musculoskeletal Pain Treatment Product Offerings
Table 101. AstraZeneca Recent Development
Table 102. Ampio Pharmaceuticals Inc. Company Information
Table 103. Ampio Pharmaceuticals Inc. Introduction and Business Overview
Table 104. Ampio Pharmaceuticals Inc. Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Ampio Pharmaceuticals Inc. Musculoskeletal Pain Treatment Product Offerings
Table 106. Ampio Pharmaceuticals Inc. Recent Development
Table 107. Eli Lilly and Company Company Information
Table 108. Eli Lilly and Company Introduction and Business Overview
Table 109. Eli Lilly and Company Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Eli Lilly and Company Musculoskeletal Pain Treatment Product Offerings
Table 111. Eli Lilly and Company Recent Development
Table 112. Novartis International AG Company Information
Table 113. Novartis International AG Introduction and Business Overview
Table 114. Novartis International AG Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Novartis International AG Musculoskeletal Pain Treatment Product Offerings
Table 116. Novartis International AG Recent Development
Table 117. Sanofi S.A. Company Information
Table 118. Sanofi S.A. Introduction and Business Overview
Table 119. Sanofi S.A. Musculoskeletal Pain Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Sanofi S.A. Musculoskeletal Pain Treatment Product Offerings
Table 121. Sanofi S.A. Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Musculoskeletal Pain Treatment Downstream Customers
Table 125. Musculoskeletal Pain Treatment Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Musculoskeletal Pain Treatment Product Picture
Figure 2. Global Musculoskeletal Pain Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Musculoskeletal Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Musculoskeletal Pain Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Musculoskeletal Pain Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Musculoskeletal Pain Treatment Report Years Considered
Figure 7. Global Musculoskeletal Pain Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Musculoskeletal Pain Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Musculoskeletal Pain Treatment Revenue in 2023
Figure 10. Musculoskeletal Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Drugs Picture
Figure 12. Intramuscular Injection Picture
Figure 13. Others Picture
Figure 14. Global Musculoskeletal Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Musculoskeletal Pain Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Musculoskeletal Pain Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Musculoskeletal Pain Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Musculoskeletal Pain Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Others
Figure 22. Global Musculoskeletal Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Musculoskeletal Pain Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Musculoskeletal Pain Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Musculoskeletal Pain Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Musculoskeletal Pain Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Musculoskeletal Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Musculoskeletal Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Musculoskeletal Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Musculoskeletal Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Musculoskeletal Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Musculoskeletal Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Musculoskeletal Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Musculoskeletal Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Musculoskeletal Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Musculoskeletal Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Musculoskeletal Pain Treatment Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Musculoskeletal Pain Treatment Sales Volume (%), (2019-2030)
Figure 39. United States Musculoskeletal Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Musculoskeletal Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Musculoskeletal Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Musculoskeletal Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Musculoskeletal Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Musculoskeletal Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. China Musculoskeletal Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Musculoskeletal Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. China Musculoskeletal Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Musculoskeletal Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Musculoskeletal Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Musculoskeletal Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Musculoskeletal Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Musculoskeletal Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Musculoskeletal Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Musculoskeletal Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Musculoskeletal Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Musculoskeletal Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 57. India Musculoskeletal Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Musculoskeletal Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 59. India Musculoskeletal Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 60. Musculoskeletal Pain Treatment Industrial Chain
Figure 61. Musculoskeletal Pain Treatment Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
